Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 10, 2022

FDA grants EUA for Bavarian Nordic’s Jynneos vaccine for monkeypox

Bavarian Nordic’s vaccine, Jynneos, has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) to increase vaccine supply for monkeypox.

FDA grants EUA for Bavarian Nordic’s Jynneos vaccine for monkeypox